首页 › 基金 › Nan Fung Group Holdings Ltd › OCS
Nan Fung Group Holdings Ltd 对 OCS 的持仓历史
OCULIS HOLDING AG · 医疗保健
Nan Fung Group Holdings Ltd 在 Q3 2026 的 13F 申报中披露持有 OCS(OCULIS HOLDING AG)300,565 股,市值约 US$2.8M,约占其申报组合的 1.90%,在其申报持仓中市值排名第 16 位。 Nan Fung Group Holdings Ltd 最近 13 个申报季度中有 13 个季度披露了 OCS 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Nan Fung Group Holdings Ltd 对 OCS 的持仓演变
Nan Fung Group Holdings Ltd 于 Q3 2023 首次披露 OCS 持仓:606,684 股(约 US$6.7M)。 该持仓在 Q4 2025 达到峰值 514,702 股,市值约 US$10.3M。 在 13 次申报中,Nan Fung Group Holdings Ltd 1 次增持、4 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 300,565 股、市值约 US$2.8M。 持仓曾出现大幅变动:Q1 2026 减持约 32% (随后一个季度股价下跌 48%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 606.68K | $6.67M | 新进 |
| Q4 2023 | 518.93K | $5.83M | 减持 |
| Q1 2024 | 436.38K | $5.26M | 减持 |
| Q2 2024 | 436.38K | $5.21M | 持有 |
| Q3 2024 | 436.38K | $5.35M | 持有 |
| Q4 2024 | 436.38K | $7.42M | 持有 |
| Q1 2025 | 514.70K | $9.79M | 增持 |
| Q2 2025 | 514.70K | $9.99M | 持有 |
| Q3 2025 | 514.70K | $9.05M | 持有 |
| Q4 2025 | 514.70K | $10.28M | 持有 |
| Q1 2026 | 350.75K | $9.33M | 减持 |
| Q2 2026 | 300.56K | $4.17M | 减持 |
| Q3 2026 | 300.56K | $2.81M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OCS 与 13F 数据
OCS(OCULIS HOLDING AG)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 OCS,申报仓位最大的包括:EQT Fund Management S.a r.l. (US$64.9M), Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$15.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OCS 的基金
- EQT Fund Management S.a r.l. 6.95M 股 · $64.92M · Q3 2026
- Gildi - lifeyrissjodur 2.43M 股 · $64.32M · Q1 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.66M 股 · $15.49M · Q3 2026
- Saturn V Capital Management LP 684.88K 股 · $9.50M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 641.02K 股 · $8.89M · Q2 2026
- SYQUANT CAPITAL SAS 375.00K 股 · $2.82M · Q3 2026
- Checkpoint Capital L.P. 99.50K 股 · $929.33K · Q3 2026
- Marble Bar Asset Management LLP 14.81K 股 · $205.36K · Q2 2026
- DUPONT CAPITAL MANAGEMENT CORP 4 股 · $37.00K · Q3 2026
更多关于 Nan Fung Group Holdings Ltd
常见问题
How long has Nan Fung Group Holdings Ltd held OCS?
Nan Fung Group Holdings Ltd has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nan Fung Group Holdings Ltd's current position in OCS?
As of Q3 2026, Nan Fung Group Holdings Ltd holds 300.56K shares of OCS (OCULIS HOLDING AG), valued at $2.81M, representing 1.90% of its reported portfolio and ranking #16.
Has Nan Fung Group Holdings Ltd been buying or selling OCS?
In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in OCS. The position peaked in Q4 2025 at 514.70K shares.
Which other funds hold OCS?
Other major institutional holders of OCS include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.